Review of 2006 Corporate Experience

Review of 2006 Corporate Experience

Publications

Selected 2006 Public Offerings and Rule 144A Placements (PDF Version)

  • Achillion Pharmaceuticals — Initial Public Offering of Common Stock — $59,512,500 — Counsel to Issuer
  • Acme Packet — Initial Public Offering of Common Stock — $116,584,000 — Counsel to Underwriters
  • Alexion Pharmaceuticals — Public Offering of Common Stock — $148,350,000 — Counsel to Underwriters
  • Alnylam Pharmaceuticals — Public Offerings of Common Stock — $165,917,000 — Counsel to Issuer
  • Altus Pharmaceuticals — Initial Public Offering of Common Stock — $120,750,000 — Counsel to Underwriters
  • CapitalSource — Public Offering of Common Stock — $414,000,000 — Counsel to Underwriters
  • Ciena — Public Offering of 0.25% Convertible Senior Notes due 2013 — $300,000,000 — Counsel to Underwriters
  • CIGNA — Public Offering of 6.150% Senior Notes due 2036 — $250,000,000 — Counsel to Issuer
  • CIT Group — Public Offerings of Medium-Term Notes — $16,350,216,000 — Counsel to Underwriters and Agents
  • CollaGenex Pharmaceuticals — Public Offering of Common Stock — $45,500,000 — Counsel to Issuer
  • Corporación Andina de Fomento — Public Offering of 5.75% Notes Due 2017 — $250,000,000 — Counsel to Underwriters
  • CTC Media — Initial Public Offering of Common Stock — $380,525,000 — Counsel to Issuer
  • Cubist Pharmaceuticals — Public Offering of 2.25% Convertible Subordinated Notes due 2013 — $350,000,000 — Counsel to Underwriters
  • Dean Foods — Public Offering of 7.000% Senior Notes due 2016 — $500,000,000 — Counsel to Issuer
  • Emergent BioSolutions — Initial Public Offering of Common Stock — $62,500,000 — Counsel to Issuer
  • Evercore Partners — Initial Public Offering of Common Stock — $95,392,500 — Counsel to Underwriters
  • Globalstar — Initial Public Offering of Common Stock — $146,625,000 — Regulatory Counsel to Issuer
  • GTx — Public Offering of Common Stock — $60,793,600 — Counsel to Underwriters
  • Labopharm — Initial Public Offering of Common Stock — $101,200,000 — Counsel to Underwriters
  • LeMaitre Vascular — Initial Public Offering of Common Stock — $38,500,000 — Counsel to Underwriters
  • MBB Industries — Initial Public Offering of Common Stock — €17,480,000 — Counsel to Issuer
  • Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
  • Millennium Pharmaceuticals — Public Offering of 2.25% Convertible Senior Notes due 2011 — $250,000,000 — Counsel to Issuer
  • NitroMed — Public Offering of Common Stock — $62,504,500 — Counsel to Issuer
  • NxStage Medical — Public Offering of Common Stock — $56,336,000 — Counsel to Issuer
  • Optos — Initial Public Offering of Ordinary Shares — £50,000,000 — Counsel to Issuer
  • PS Business Parks — Public Offerings of Preferred Stock — $94,600,000 — Counsel to Underwriters
  • SS&C Technologies — Exchange Offer for 11 3/4% Senior Subordinated Notes due 2013 — $205,000,000 — Counsel to Issuer
  • Speedel — Public Offering of Common Stock — CHF 96,541,500 — Counsel to Issuer
  • Targacept — Initial Public Offering of Common Stock — $45,000,000 — Counsel to Underwriters
  • TEMENOS Group — Public Offering of 1.5% Convertible Bonds due 2013 — CHF 132,500,000 — Counsel to Issuer
  • Visicu — Initial Public Offering of Common Stock — $110,400,000 — Counsel to Underwriters
  • Watts Water Technologies — Public Offering of Common Stock — $230,000,000 — Counsel to Issuer
  • World Energy Solutions — Initial Public Offering of Common Stock — $25,525,000 — Counsel to Issuer

Selected 2006 M&A Transactions (PDF Version)

  • Akamai Technologies — acquisition of Nine Systems — $160,000,000
  • Arlington Tankers — asset acquisition from Stena Group — $92,000,000
  • Becton Dickinson — acquisition of GeneOhm Sciences — $230,000,000
  • Blackstone — sale of Kabel BW to EQT — undisclosed
  • BrassRing — acquisition by Kenexa — $115,000,000
  • Danaher — acquisition of Sybron Dental Specialties — $2,200,000,000 (co-counsel)
  • Domantis — acquisition by GSK — £230,000,000
  • GeoTrust — acquisition by VeriSign — $125,000,000
  • GlycoFi — acquisition by Merck — $400,000,000
  • HMS Holdings — acquisition of the Benefits Solutions Practice Area division of Public Consulting Group — $100,000,000
  • IDEXX Laboratories — acquisition of Osmetech's Critical Care Division — $44,900,000*
  • IDX Systems — acquisition by GE Healthcare — $1,200,000,000
  • I-Logix — acquisition by Telelogic — $80,000,000
  • IMLogic — acquisition by Symantec — $90,000,000
  • Infinity Pharmaceuticals — acquisition of Discovery Partners — $162,500,000
  • Kronos — acquisition of Unicru — $150,000,000
  • Lifeline Systems — acquisition by Philips Electronics — $750,000,000
  • Linde — acquisition of BOC Group — $14,800,000,000 (worldwide antitrust counsel)
  • Lucent — merger with Alcatel — $13,000,000,000 (US CFIUS counsel and worldwide antitrust co-counsel)
  • MatrixOne — acquisition by Dassault Systèmes — $408,000,000
  • PAREXEL International — acquisition of California Clinical Trials Medical Group and Behavioral and Medical Research — $65,000,000
  • PepsiCo — acquisition of Stacy's Pita Chip Company — undisclosed
  • Red Hat — acquisition of JBoss — $420,000,000 (including earnout)
  • RSA Security — acquisition by EMC — $2,300,000,000
  • Savient Pharmaceuticals — sale of oral liquid pharmaceuticals business to Close Brothers Private Equity — $176,000,000
  • SkillSoft — acquisition of NETg from Thomson — $285,000,000*
  • Softricity — acquisition by Microsoft — undisclosed
  • Thermo Fisher Scientific — acquisition of Cohesive Technologies — undisclosed
  • Verizon Communications — acquisition of MCI — $8,500,000,000 (regulatory counsel)
  • WebMD — acquisition of Subimo — $60,000,000
  • WiderThan — acquisition by RealNetworks — $350,000,000

Selected 2006 Venture Financings As Company Counsel (PDF Version)

  • Acopia Networks — $20,000,000
  • Adnexus Therapeutics — $27,000,000
  • Airwide Solutions — $25,000,000
  • Akorri — $15,000,000
  • A123 Systems — $30,000,000
  • Archivas — $12,000,000
  • Aushon BioSystems — $7,800,000
  • Axsun Technologies — $15,000,000
  • BlueNote Networks — $15,000,000
  • Codon Devices — $20,000,000
  • Egenera — $26,000,000
  • Gigle Semiconductor — $11,000,000
  • GloNav — $16,200,000
  • Icera — $40,000,000
  • IGA Worldwide — $17,000,000
  • Incipient — $24,000,000
  • IntelliVid — $8,000,000
  • Intercept Pharmaceuticals — $41,000,000
  • Mintera — $10,000,000
  • NanoNexus — $32,000,000
  • Njini — $13,000,000
  • Partsearch Technologies — $10,750,000
  • Pivot Solutions — $8,000,000
  • Reflexis Systems — $10,000,000
  • Scanbuy — $9,000,000
  • SiCortex — $21,000,000
  • SmartBargains — $10,000,000
  • SupplyScape — $8,000,000
  • Tetraphase Pharmaceuticals — $25,000,000
  • Transitive — $12,250,000
  • TransMedics — $29,750,000
  • UbiquiSys — $12,000,000
  • U3 Pharma — €27,000,000
  • WeeWorld — $15,500,000
  • Xanthus Pharmaceuticals — $25,000,000
  • Zipcar — $25,000,000
  • Zopa — $15,000,000

Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions (PDF Version)

  • Airwide Solutions — US and international reseller and sales agreements
  • Alantos Pharmaceuticals — Collaboration with Servier for oral administration treatment for type 2 diabetes
  • Alnylam Pharmaceuticals — Collaboration with Novartis Institutes for BioMedical Research to develop RNAi therapeutics for pandemic flu
  • Applix — International software solution partner agreement
  • AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
  • Avid — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
  • Bose — Various licensing and collaboration matters
  • Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
  • Broadcom — Licenses in connection with various acquisitions
  • Brooks Automation — Formation of Japanese joint venture with Yaskawa Electric
  • Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
  • Constant Contact — Various co-promotion and licensing matters
  • Emergent BioSolutions — Supply agreements for a therapeutic anthrax immune globulin product
  • From the Top — Agreements with WGBH, Carnegie Hall and others for production of public television series
  • Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
  • IETF — Advice to the leading standards body for the Internet
  • IGA Worldwide — Online game advertising agreement with Electronic Arts
  • Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
  • Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
  • Palm — Various patent licenses
  • Panera Bread — Licensing and supply arrangements for Canadian retail expansion
  • PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
  • ReGen Therapeutics — Distribution and marketing of nutraceutical compounds through Metagenics
  • SiCortex — Various development, manufacturing, services and distribution agreements
  • Silicon Integration Initiative — Formation of low-power integrated circuit design flow coalition
  • Starent Networks — International distribution agreements and licensing transactions
  • Sucampo Pharmaceuticals — Licensing advice in connection with corporate reorganization
  • Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
  • Xanthus — Acquisition from Schering AG of rights to clinical-stage cancer compounds
  • Ziopharm — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Selected 2006 Information Technology Transactions (PDF Version)

Venture Capital Financings

  • Acopia Networks — $20,000,000
  • Airwide Solutions — $25,000,000
  • Axsun Technologies — $15,000,000
  • BlueNote Networks — $15,000,000
  • Egenera — $26,000,000
  • Icera — $40,000,000
  • Incipient — $24,000,000
  • NanoNexus — $32,000,000
  • Reflexis Systems — $10,000,000
  • SiCortex — $21,000,000
  • SmartBargains — $10,000,000

Licensing, Outsourcing and Alliances

  • Applix — International software solution partner agreement
  • Avid — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
  • Bose — Various licensing and collaboration matters
  • Broadcom — Licenses in connection with various acquisitions
  • Constant Contact — Various co-promotion and licensing matters
  • Columbia University — Advice regarding open source and proprietary software licensing
  • IETF — Advice to the leading standards body for the Internet
  • IGA Worldwide — Online game advertising agreement with Electronic Arts
  • Palm — Various patent licenses
  • Starent Networks — International distribution agreements and licensing transactions
  • State Street — Outsourcing of financial services functions for major mutual funds and institutions

Public Offerings and Rule 144A Placements

  • Acme Packet — Initial Public Offering of Common Stock — $116,584,000 — Counsel to Underwriters
  • Ciena — Public Offering of 0.25% Convertible Senior Notes due 2013 — $300,000,000 — Counsel to Underwriters
  • Globalstar — Initial Public Offering of Common Stock — $146,625,000 — Regulatory Counsel to Issuer
  • Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
  • Optos — Initial Public Offering of Ordinary Shares — £50,000,000 — Counsel to Issuer
  • SS&C Technologies — Exchange Offer for 11 3/4% Senior Subordinated Notes due 2013 — $205,000,000 — Counsel to Issuer
  • TEMENOS Group — Public Offering of 1.5% Convertible Bonds due 2013 — CHF 132,500,000 — Counsel to Issuer
  • Watts Water Technologies — Public Offering of Common Stock — $230,000,000 — Counsel to Issuer
  • World Energy Solutions — Initial Public Offering of Common Stock — $25,525,000 — Counsel to Issuer

Mergers and Acquisitions

  • Akamai Technologies — acquisition of Nine Systems — $160,000,000
  • Blackboard — acquisition of WebCT — $180,000,000
  • Danaher — acquisition of Sybron Dental Specialties — $2,200,000,000 (co-counsel)
  • Kronos — acquisition of Unicru — $150,000,000
  • IMLogic — acquisition by Symantec — $90,000,000
  • MatrixOne — acquisition by Dassault Systèmes — $408,000,000
  • Red Hat — acquisition of JBoss — $420,000,000 (including earnout)
  • RSA Security — acquisition by EMC — $2,300,000,000
  • SkillSoft — acquisition of NETg from Thomson — $285,000,000*
  • WebMD — acquisition of Subimo — $60,000,000
  • WiderThan — acquisition by RealNetworks — $350,000,000

Selected 2006 Life Sciences Transactions (PDF Version)

Venture Capital and PIPEs Financings

  • Adnexus Therapeutics — $27,000,00
  • Aushon BioSystems — $7,800,000
  • BioSphere Medical — $14,525,000
  • Codon Devices — $20,000,000
  • Intercept Pharmaceuticals — $41,000,000
  • Tetraphase Pharmaceuticals — $25,000,000
  • TransMedics — $29,750,000
  • U3 Pharma — €27,000,000
  • Xanthus Pharmaceuticals — $25,000,000

Strategic Alliances and Collaborations

  • AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
  • Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
  • Bristol-Myers Squibb — Licensing advice for drug discovery and development agreements
  • Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
  • Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
  • Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
  • Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
  • Novartis — License by Novartis Pharma to Cerimon of Simulect® antibody for treatment of inflammatory bowel disease
  • PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
  • Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
  • Ziopharm Oncology — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Public Offerings and Rule 144A Placements

  • Achillion Pharmaceuticals — Initial Public Offering of Common Stock — $59,512,500 — Counsel to Issuer
  • Alexion Pharmaceuticals — Public Offering of Common Stock — $148,350,000 — Counsel to Underwriters
  • Alnylam Pharmaceuticals — Public Offerings of Common Stock — $165,917,000 — Counsel to Issuer
  • Altus Pharmaceuticals — Initial Public Offering of Common Stock — $120,750,000 — Counsel to Underwriters
  • CollaGenex Pharmaceuticals — Public Offering of Common Stock — $45,500,000 — Counsel to Issuer
  • Emergent BioSolutions — Initial Public Offering of Common Stock — $62,500,000 — Counsel to Issuer
  • Labopharm — Initial Public Offering of Common Stock — $101,200,000 — Counsel to Underwriters
  • LeMaitre Vascular — Initial Public Offering of Common Stock — $38,500,000 — Counsel to Underwriters
  • Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
  • Millennium Pharmaceuticals — Public Offering of 2.25% Convertible Senior Notes due 2011 — $250,000,000 — Counsel to Issuer
  • NxStage Medical — Public Offering of Common Stock — $56,336,000 — Counsel to Issuer

Mergers and Acquisitions

  • Becton Dickinson — Acquisition of GeneOhm Sciences — $230,000,000
  • Domantis — Acquisition by GSK — £230,000,000
  • GlycoFi — Acquisition by Merck — $400,000,000
  • HMS Holdings — Acquisition of the Benefits Solutions Practice Area division of Public Consulting Group — $100,000,000
  • IDX Systems — Acquisition by GE Healthcare — $1,200,000,000
  • Infinity Pharmaceuticals — Acquisition of Discovery Partners — $162,500,000
  • Lifeline Systems — Acquisition by Philips Electronics — $750,000,000
  • PAREXEL International — Acquisition of California Clinical Trials Medical Group and Behavioral and Medical Research — $65,000,000
  • Savient Pharmaceuticals — Sale of oral liquid pharmaceuticals business to Close Brothers Private Equity — $176,000,000
  • Thermo Fisher Scientific — Acquisition of Cohesive Technologies — undisclosed
  • WebMD — Acquisition of Subimo — $60,000,000

*pending